Metabolic Control in Diabetic Patients: Effect of Insulin-secretory Reserve (Measured by Plasma C-Peptide Levels) and Circulating Insulin Antibodies

We measured circulating hemoglobin A1 (HbA1) and fasting plasma C-peptide concentrations in 100 diabetic patients. Pancreatic insulin reserve showed a negative correlation with HbA1 concentrations in nonobese, insulin-treated patients but not in obese patients, whether they were treated with insulin, oral agent, or diet alone. Patients with fasting C-peptide concentrations above 0.1 pmol/ml had significantly better metabolic control than did those with lower values. Anti-insulin antibodies were measured in 37 patients. There was no correlation between metabolic control and the affinity constants or binding capacities of these antibodies.

[1]  J. Goldman,et al.  Equilibrium Binding Assay and Kinetic Characterization of Insulin Antibodies , 1978, Diabetes.

[2]  D. Goldie,et al.  The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics. , 1978, Acta Endocrinologica.

[3]  R. Baxter,et al.  C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus. , 1978, Metabolism: clinical and experimental.

[4]  S. Tarui,et al.  Studies on the Etiology of “Brittle Diabetes”: Relationship Between Diabetic Instability and Insulinogenic Reserve , 1977, Diabetes.

[5]  P. Gallop,et al.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. , 1977, The Journal of clinical endocrinology and metabolism.

[6]  W. F. Taylor,et al.  Abnormalities of Endogenous Glucagon and Insulin in Unstable Diabetes , 1977, Diabetes.

[7]  R. Pildes,et al.  Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity. , 1977, Jornal de Pediatria.

[8]  J. Olefsky.  The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes , 1976, Diabetes.

[9]  A. Cerami,et al.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. , 1976, The New England journal of medicine.

[10]  C. Kilo,et al.  Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes , 1976, Diabetes.

[11]  D. Steiner,et al.  Clinical significance of circulating proinsulin and C-peptide. , 1976, Recent progress in hormone research.

[12]  P. Gallop,et al.  Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. , 1975, Biochemical and biophysical research communications.

[13]  J. Malins,et al.  Insulin antibodies and the control of diabetes. , 1975, The Quarterly journal of medicine.

[14]  D. Steiner,et al.  Circulating C-peptide Immunoreactivity: Studies in Normals and Diabetic Patients , 1972, Diabetes.

[15]  H. Ranney,et al.  Hemoglobin components in patients with diabetes mellitus. , 1971, The New England journal of medicine.

[16]  D. Steiner,et al.  Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood , 1969, Nature.

[17]  O. Blumenfeld,et al.  Studies of an unusual hemoglobin in patients with diabetes mellitus. , 1969, Biochemical and biophysical research communications.

[18]  P. Gallop,et al.  Structure of hemoglobin AIc: nature of the N-terminal beta chain blocking group. , 1968, Biochemical and biophysical research communications.

[19]  R. Harwood.  Insulin-binding antibodies and "spontaneous" hypoglycemia. , 1960, The New England journal of medicine.